Bronchial Vascular Remodeling Is Attenuated by Anti-IL-17 in Asthmatic Responses Exacerbated by LPS-Reference-Cited by-同舟云学术

Bronchial Vascular Remodeling Is Attenuated by Anti-IL-17 in Asthmatic Responses Exacerbated by LPS

Published:2020-09-04 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Camargo Leandro do Nascimento,Santos Tabata Maruyama dos,Andrade Felipp Costa Pinto de,Fukuzaki Silvia,dos Santos Lopes Fernanda Degobbi Tenorio Quirino,de Arruda Martins Milton,Prado Carla Máximo,Leick Edna Aparecida,Righetti Renato Fraga,Tibério Iolanda de Fátima Lopes Calvo

Funder

Fundação de Amparo á Pesquisa do Estado de São Paulo

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference55 articles.

1. Relationships between adult asthma and oxidative stress markers and pH in exhaled breath condensate: a systematic review;Aldakheel;Allergy,2016

2. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma;Al-Ramli;J. Allergy Clin. Immunol.,2009

3. Effects of chronic L-NAME treatment lung tissue mechanics, eosinophilic and extracellular matrix responses induced by chronic pulmonary inflammation;Angeli;Am. J. Physiol. Lung Cell. Mol. Physiol.,2008

4. Extracellular matrix components and regulators in the airway smooth muscle in asthma;Araujo;Eur. Respir. J.,2008

5. Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects;Asai;J. Allergy Clin. Immunol.,2002

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental Insights on the Use of Secukinumab and Magnolol in Acute Respiratory Diseases in Mice;Biomedicines;2024-07-11

2. Network pharmacology analysis and experimental validation of Xiao-Qing-Long-Tang’s therapeutic effects against neutrophilic asthma;Journal of Pharmaceutical and Biomedical Analysis;2024-06

3. Impact of obesity on airway remodeling in asthma: pathophysiological insights and clinical implications;Frontiers in Allergy;2024-03-18

4. Targeting Common Inflammatory Mediators in Experimental Severe Asthma and Acute Lung Injury;Pharmaceuticals;2024-03-05

5. Modulating asthma–COPD overlap responses with IL-17 inhibition;Frontiers in Immunology;2023-10-27